BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 33807389)

  • 1. miRNAs Involved in Esophageal Carcinogenesis and miRNA-Related Therapeutic Perspectives in Esophageal Carcinoma.
    Zarrilli G; Galuppini F; Angerilli V; Munari G; Sabbadin M; Lazzarin V; Nicolè L; Biancotti R; Fassan M
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the current understanding and clinical utility of miRNAs in esophageal cancer.
    Sakai NS; Samia-Aly E; Barbera M; Fitzgerald RC
    Semin Cancer Biol; 2013 Dec; 23(6 Pt B):512-21. PubMed ID: 24013023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma.
    Slaby O; Srovnal J; Radova L; Gregar J; Juracek J; Luzna P; Svoboda M; Hajduch M; Ehrmann J
    Carcinogenesis; 2015 May; 36(5):521-7. PubMed ID: 25784377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis.
    Yang H; Su H; Hu N; Wang C; Wang L; Giffen C; Goldstein AM; Lee MP; Taylor PR
    BMC Cancer; 2020 May; 20(1):388. PubMed ID: 32375686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ESOMIR: a curated database of biomarker genes and miRNAs associated with esophageal cancer.
    Sindhoo A; Sipy S; Khan A; Selvaraj G; Alshammari A; Casida ME; Wei DQ
    Database (Oxford); 2023 Oct; 2023():. PubMed ID: 37815872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in Esophageal Adenocarcinoma: Functional Significance and Potential for the Development of New Molecular Disease Markers.
    Bobryshev YV; Orekhov AN; Chistiakov DA
    Curr Pharm Des; 2015; 21(23):3402-16. PubMed ID: 25758856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of MicroRNAs in the progression of barrett esophagus to adenocarcinoma in a long-term follow-up study.
    Revilla-Nuin B; Parrilla P; Lozano JJ; de Haro LF; Ortiz A; Martínez C; Munitiz V; de Angulo DR; Bermejo J; Molina J; Cayuela ML; Yélamos J
    Ann Surg; 2013 May; 257(5):886-93. PubMed ID: 23059500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential role of microRNAs in the pathogenesis and treatment of Esophageal cancer.
    Hemmatzadeh M; Mohammadi H; Karimi M; Musavishenas MH; Baradaran B
    Biomed Pharmacother; 2016 Aug; 82():509-19. PubMed ID: 27470391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
    Whitson MJ; Falk GW
    Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.
    Sreedharan L; Mayne GC; Watson DI; Bright T; Lord RV; Ansar A; Wang T; Kist J; Astill DS; Hussey DJ
    World J Gastroenterol; 2017 Aug; 23(30):5508-5518. PubMed ID: 28852310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs in esophageal squamous cell carcinoma: Application in prognosis, diagnosis, and drug delivery.
    Mohammadi E; Aliarab A; Babaei G; Habibi NK; Jafari SM; Mir SM; Memar MY
    Pathol Res Pract; 2022 Dec; 240():154196. PubMed ID: 36356334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett's esophagus, dysplasia and adenocarcinoma.
    Huhta H; Helminen O; Lehenkari PP; Saarnio J; Karttunen TJ; Kauppila JH
    Oncotarget; 2016 Apr; 7(17):23658-67. PubMed ID: 27008696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
    Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
    Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of insulin-like growth factor II mRNA-binding protein 3 (IMP3) as a new marker for the diagnosis of esophageal adenocarcinoma in challenging cases.
    Kazeminezhad B; Mirafsharieh SA; Dinyari K; Azizi D; Ebrahimi A
    Turk J Gastroenterol; 2014 Jun; 25(3):253-6. PubMed ID: 25141312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium.
    Drahos J; Schwameis K; Orzolek LD; Hao H; Birner P; Taylor PR; Pfeiffer RM; Schoppmann SF; Cook MB
    Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):429-37. PubMed ID: 26604271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagus.
    Stairs DB; Nakagawa H; Klein-Szanto A; Mitchell SD; Silberg DG; Tobias JW; Lynch JP; Rustgi AK
    PLoS One; 2008; 3(10):e3534. PubMed ID: 18953412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus.
    Guillem P; Billeret V; Buisine MP; Flejou JF; Lecomte-Houcke M; Degand P; Aubert JP; Triboulet JP; Porchet N
    Int J Cancer; 2000 Dec; 88(6):856-61. PubMed ID: 11093805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying potential metastasis-related long non-coding RNAs, microRNAs, and message RNAs in the esophageal squamous cell carcinoma.
    Yang F; Wen S; Zhang Y; Xu Y; Lv H; Zhu Y; Wang M; Su P; Huang C; Tian Z
    J Cell Biochem; 2019 Aug; 120(8):13202-13215. PubMed ID: 30891809
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Fang HY; Münch NS; Schottelius M; Ingermann J; Liu H; Schauer M; Stangl S; Multhoff G; Steiger K; Gerngroß C; Jesinghaus M; Weichert W; Kühl AA; Sepulveda AR; Wester HJ; Wang TC; Quante M
    Clin Cancer Res; 2018 Mar; 24(5):1048-1061. PubMed ID: 29208671
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
    Lord RV; Brabender J; Wickramasinghe K; DeMeester SR; Holscher A; Schneider PM; Danenberg PV; DeMeester TR
    Surgery; 2005 Nov; 138(5):924-31. PubMed ID: 16291394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.